24 May 2013
Keywords: ec, cpmp, backs, taxol, approval, paclitaxel, promising
Article | 27 September 1993
Taxol (paclitaxel), the promising new anticancer drug developed by
Bristol-Myers Squibb, has been unanimously backed for approval in Europe
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 September 1993
20 September 1993
23 May 2013
© 2013 thepharmaletter.com